September 21-25, 2020
Now Delivered as a 100% Virtual Conference & Exhibition,
Eastern Standard Time Zone (EST)
Access in-depth functional and phase-based innovations, trends and technologies across the entire bioprocessing spectrum
Why Choose BioProcess International's Virtual Conference & Exhibition?
BioProcess International's Virtual Conference & Exhibition is not just another webinar or zoom call.
Watch our highlight video and see why the global bioprocessing industry chooses BPI as the #1 brand to access the innovative science, technologies and contacts needed to drive the industry forward.
Hear from the brightest minds in bioprocessing
Improve the speed, lower the cost and increase the quality/safety of biologics development
Manufacturing Strategy & Bioprocessing 4.0
Manufacturing Strategy & Bioprocessing 4.0
Apply digital technologies, artificial intelligence and machine learning to increase manufacturing efficiency through smart and data-driven bioprocessing.
Cell Culture & Upstream Processing
Cell Culture & Upstream Processing
Optimize speed, titers, efficiency and quality in upstream process development.
Recovery & Purification
Recovery & Purification
Apply novel technologies that are enabling next generation downstream processes to overcome bottlenecks and optimize manufacturing, quality and control of emerging modalities.
Analytical & Quality, Speed from Gene to Market
Analytical & Quality, Speed from Gene to Market
Achieve a high quality product using optimal analytical strategies while reducing timelines. Gain the industry insights you need to accelerate speed and compress timelines to IND and BLA submissions.
Intensified & Continuous Processing
Intensified & Continuous Processing
Accelerate manufacturing timelines by achieving intensified and fully continuous processing from the development, optimization and implementation of novel technologies, analytical tools and automated systems.
Cell Line Development & Engineering
Cell Line Development & Engineering
Perfect your biologics and optimize CHO through targeted integration, systems biology, automation and novel cell lines.